3 Fabulous Dividend Stocks to Buy in February
February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three Motley Fool contributors believe they have identified fabulous dividend stocks to buy this month. Here's why they like (NYSE: ABBV), Amgen (NASDAQ: AMGN), and Gilead Sciences (NASDAQ: GILD).
Keith Speights (AbbVie): AbbVie has been a longtime favorite for income investors. The big drugmaker's 52 consecutive years of dividend increases (including when it was part of Abbott) qualify it as a Dividend King. Its forward dividend yield is a juicy 3.4%.
For a while, though, AbbVie might not have been viewed as a fabulous pick by many investors. Humira, the company's top-selling drug for years, lost U.S. patent exclusivity in early 2023. As a result, revenue and profits began to sink.
Source Fool.com
AbbVie Inc. Stock
With 38 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 209 € there is a slightly positive potential of 9.77% for AbbVie Inc. compared to the current price of 190.4 €.
